"Baxter International (NYSE: BAX) benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates," says Richard Moroney. In Dow Theory Forecasts, he explains, "The ?rst company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical products since 1931." Here's his bullish [More...]
Following its November 16-19 meetings, the European Medicines Agency (EMEA) says it has reviewed further data on the centrally authorized pandemic vaccines, Celvapan (from Baxter International), Focetria (from Novartis) and Pandemrix (from GlaxoSmithKline). The Agency has reaffirmed that they have a positive balance of benefits and risks in the context of the current H1N1 influenza pandemic.
Joseph Moshe Update: November 18, 2009 According to Europe Business Blog: "Joseph Moshe, the dual national (Israeli-American) Mossad biowar expert, who was attacked and seized by Federal Agents and LAPD in mid-August in California, after speaking to Dr. True Ott on his national radio show and warning of a plot by Baxter International to spread a Plague from Baxter's Ukrainian lab, IS BEING HELD...
From http://www.infowars.com/scientist-warned-baxter-would-release-plague-in-ukraine/ Scientist Warned Baxter Would Release Plague in Ukraine Text size NoWorldSystem November 21, 2009 Bio-scientist Joseph Moshe who was arrested by the FBI tried to warn the public about Baxter’s sinister plan to release a plague in the Ukraine by creating a vaccine bio-weapon that would result in hundreds of deaths....
According to the recent TIM (Trade Ideas Monitor) report for the week of November 13-19, 2009, the TIM Sentiment Index (TSI) increased 0.85 points to 55.29, staying within bullish territory (see last week's post and the youDevise website for additional information on the TIM report, a reading above 50 is bullish). On the other hand, the TSI Worldwide Index dropped 4.61 points to 47.13, falling in bearish...
Baxter teams up with Northwestern : A treatment that uses adult stem cells to rebuild failing hearts reduced chest pain and improved activity levels for severely ill patients one year after injection, a Northwestern University researcher working with a Chicago-area device-maker reported. Though still in early development stages, the work of Dr. Douglas Losordo, using technology developed by Baxter...
Their reported Radio City Music Hall showdown in New York may be off, but former Presidents George W. Bush and Bill Clinton are scheduled for a joint appearance to talk biotechnology next May in the more low-key environs of the Second City. The Biotechnology Industry Organization's annual meeting May 3-6 in Chicago will serve as backdrop for the two former leaders in what the group says will have...
by Stephen Lendman - November 11, 2009 - ...A November 1 David Rothscum infowars.com article headlined: "Has Baxter International released a biological weapon," in citing an earlier Huffington Post report on a man named Joseph Moshe, a Mossad biological warfare expert. True or not, he warned, on an August radio program, about "a biological weapon....being made by Baxter International('s...
Baxter International (NYSE: BAX) opened at $56.86. So far today, the stock has hit a low of $54.58 and a high of $56.86. BAX is now trading at $54.93, down $2.21 (-3.86%). Over the last 52 weeks the stock has ranged from a low of $45.46 to a high of $62.50. BAX shares are falling with other stocks this morning after news of a decline in same-store sales at retail giant Wal-Mart (WMT) reignited worries...
Sentinel Radio Blog and Investigating Obama will continue to monitor both the Ukrainian pneumonia-like outbreak and the alarmingly related story of Moshe Bar-Joseph, the scientist arrested this August in Los Angeles County, after warning people about an upcoming, intentional virus outbreak in the Ukraine, and being targeted for America -- and using "vaccine" to do its dirty work. From Sentinel...
The Dividend Aristocrats index measures the performance of S&P 500 index members that have followed a policy of consistently increasing dividends every year for at least 25 consecutive years. (Source: S&P ) Since its inception 20 years ago, the dividend aristocrat’s index has outperformed the S&P 500. The number of components in the index has ranged between 26 in 1989 to 64 in 2001....
Baxter International Inc. (NYSE: BAX) commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis...
NEW YORK (MarketWatch)-- Baxter International Inc. said Tuesday that its board declared a quarterly dividend of 29 cents a share, representing about a 12% increase over the previous rate of 26 cents a share. The medical-products company said that the dividend is payable Jan. 5 to shareholders of record as of Dec. 10. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they...
DEERFIELD, Ill.--(BUSINESS WIRE)--The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.29 per Baxter common share. This represents an increase of approximately 12 percent over the previous quarterly rate of $0.26 per share. The dividend is payable on January 5, 2010, to shareholders of record as of the close of business on December 10, 2009. Baxter...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis...
Videos